Biosurfit receives CE mark for microfluidic COVID test

Congratulations, biosurfit !

We are excited about our customer biosurfit’s successful launch of their spinit® COVID Antibody point-of-care blood test. With this launch biosurfit adds one more relevant parameter to spinit, the first and only, PoC diagnostic system capable of performing all three of the major blood tests (haematology, immunoassays, and clinical chemistry) on the same instrument.

Axxicon is proud to be development and manufacturing partner for biosurfit for the microfluidic consumable disc. 

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published.